Histopathological analysis and demonstration of EBV and HIV p-24 antigen but not CMV expression in labial minor salivary glands of HIV patients affected by diffuse infiltrative lymphocytosis syndrome

Journal of Oral Pathology and Medicine

Volumn 32, Issue 7, 2003, Pages 431-437

  Rivera, Helen ^a   Nikitakis, Nikolaos G ^a,b   Castillo, Sleygh ^c   Siavash, Hessam ^a   Papadimitriou, John C ^a   Sauk, John J ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^c NONE

Author keywords

CMV; DILS; EBV; HIV; p 24

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN; GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; VIRUS PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; DIFFUSE INFILTRATIVE LYMPHOCYTOSIS SYNDROME; EPSTEIN BARR VIRUS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; LYMPHOCYTOSIS; MALE; MINOR SALIVA GLAND; PAROTID GLAND; PATHOGENESIS; SALIVARY GLAND BIOPSY;

ADULT; ANTIGENS, VIRAL; CAPSID; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; FEMALE; HERPESVIRUS 4, HUMAN; HIV CORE PROTEIN P24; HIV INFECTIONS; HUMANS; LYMPHOCYTOSIS; MALE; MIDDLE AGED; PAROTID DISEASES; SALIVARY DUCTS; SALIVARY GLAND DISEASES; SALIVARY GLANDS, MINOR; SYNDROME; VIRAL MATRIX PROTEINS; XEROSTOMIA;

EID: 0038033865     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0714.2003.00061.x     Document Type: Article

References (32)

1. Schiodt M, Greenspan D, Daniels TE, et al. Parotid gland enlargement and xerostomia associated with labial sialoadenitis in HIV-infected patients. J Autoimmun 1985; 2: 415-25.
2. Schrot RJ, Adelman HM, Linden CN, Wallach PM. Cystic parotid gland enlargement in HIV disease. The diffuse infiltrative lymphocytosis syndrome. JAMA 1997; 278: 166-7.
3. Harris NL Lymphoid proliferations of the salivary glands. Am J Clin Pathol 1999; 111: S94-103.
4. Kazi S, Cohen PR, Williams F, Schempp F, Reveille JD, Reveille J. The diffuse infiltrative lymphocytosis syndrome. Clinical and immunogenetic features in 35 patients. AIDS 1996; 10: 385-91.
5. Moulignier A, Authier F, Baudrimont M, et al. Peripheral neuropathy in human immunodeficiency virus-infected patients with the diffuse infiltrative lymphocytosis syndrome. Ann Neurol 1997; 41: 438-45.
6. Williams FM, Cohen PR, Jumshyd J, Reveille JD. Prevalence of the diffuse infiltrative lymphocytosis syndrome among human immunodeficiency virus type 1-positive outpatients. Arthritis Rheumatol 1998; 41: 863-8.
7. Bachmeyer C, Dhote R, Blanche P, Tulliez M, Sicard D, Chistoforov B. Diffuse infiltrative CD8 lymphocytosis syndrome with predominant neurological manifestations in two HIV-infected patients responding to zidovudine. AIDS 1995; 9: 1101-2.
8. Mandel L, Kim D, Uy C. Parotid gland swelling in HIV diffuse infiltrative CD8 lymphocytosis syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85: 565-8.
9. Mandel L, Hong J. HIV-associated parotid lymphoepithelial cysts. J Am Dent Assoc 1999; 130: 528-32.
10. McArthur CP, Subtil-DeOliveira A, Palmer D, et al. Characteristics of salivary diffuse infiltrative lymphocytosis syndrome in West Africa. Arch Pathol Lab Med 2000; 124: 1773-9.
11. Smith PR, Cavenagh JD, Milne T, et al. Benign monoclonal expansion of CD8+ lymphocytes in HIV infection. J Clin Pathol 2000; 53: 177-81.
12. Itescu S, Winchester R. Diffuse infiltrative lymphocytosis syndrome: a disorder occurring in human immunodeficiency virus-1 infection that may present as a sicca syndrome. Rheumatol Dis Clin North Am 1992; 18: 683-97.
13. Daniels TE. Labial salivary gland biopsy in Sjögren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheumatol 1984; 27: 147-56.
14. Schiodt M. HIV-associated salivary gland disease: a review. Oral Surg Oral Med Oral Pathol 1992; 73: 164-7.
15. Itescu S, Brancato LJ, Winchester R. A sicca syndrome in HIV infection: association with HLA-DR5 and CD8 lymphocytosis. Lancet 1989; 2: 466-8.
16. Kordossis T, Paikos S, Aroni K, et al. Prevalence of Sjögren's-like syndrome in a cohort of HIV-1-positive patients: descriptive pathology and immunopathology. Br J Rheumatol 1998; 37: 691-5.
17. Mandel L, Surattanont F. Regression of HIV parotid swellings after antiviral therapy: case reports with computed tomographic scan evidence. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 94: 454-9.
18. Chetty R, Vaithilingum M, Thejpal R. Epstein-Barr virus status and the histopathological changes of parotid gland lymphoid infiltrates in HIV-positive children. Pathologv 1999; 31: 413-7.
19. Fox RI, Pearson G, Vaughan JH. Detection of Epstein-Barr virus-associated antigens and DNA in salivary gland biopsies from patients with Sjögren's syndrome. J Immunol 1986; 137: 3162-8.
20. Maitland NJ, Scully C. Frequency of EBV-DNA detection in Sjögren's syndrome. AM J Med 1994; 96: 97-8.
21. Wen S, Shimizu N, Yoshiyama H, Mizugaki Y, Shinozaki F, Takada K. Association of Epstein-Barr virus (EBV) with Sjogren's syndrome: differential EBV expression between epithelial cells and lymphocytes in salivary glands. Am J Pathol 1996; 149: 1511-7.
22. Inoue H, Tsubota K, Ono M, et al. Possible involvement of EBV-mediated alpha-fodrin cleavage for organ-specific autoantigen in Sjogren's syndrome. J Immunol 2001; 166: 5801-9.
23. Telenti A, Uehlinger DE, Marchesi F, Germann D, Malinvemi R, Matter L. Epstein-Barr virus infection in HIV-positive patients. Eur J Clin Microbiol Infect Dis 1993; 12: 601-9.
24. Cisterna R, Campelo C, Gorrino T, et al. Association between HIV and other DNA viruses in vitro. Eur J Clin Microbiol Infect Dis 1995; 14:591-6.
25. Dolcetti R, Gloghini A, De Vita S, et al. Characteristics of EBV-infected cells in HIV-related lymphadenopathy: implications for the pathogenesis of EBV-associated and EBV-unrelated lymphomas of HIV-seropositive individuals. Int J Cancer 1995; 63: 652-9.
26. Portis T, Cooper L, Dennis P, Longnecker R. The LMP2A signalosome - a therapeutic target for Epstein-Barr virus latency and associated disease. Front Biosci 2002; 7: D414-26.
27. Ioachim HL, Antonescu C, Giancotti F, Dorsett B. EBV-associated primary lymphomas in salivary glands of HIV-infected patients. Pathol Res Pract 1998; 194: 87-95.
28. Yamano S, Renard JN, Mizuno F, et al. Retrovirus in salivary glands from patients with Sjögren's syndrome. J Clin Pathol 1997; 50: 223-30.
29. Talal N, Dauphinee MJ, Dang H, Alexander SS, Hart DJ, Garry RF. Detection of serum antibodies to retroviral proteins in patients with primary Sjögren's syndrome (autoimmune exocrinopathy). Arthritis Rheumatol 1990; 33: 774-81.
30. Deas JE, Liu LG, Thompson JJ, et al. Reactivity of sera from systemic lupus erythematosus and Sjögren's syndrome patients with peptides derived from human immunodeficiency virus p-24 capsid antigen. Clin Diagn Laboratory Immunol 1998; 5: 181-5.
31. Neville B, Damm D, Allen C, Bouquot J. Oral and maxillofacial pathology, 2nd edn. Philadelphia: W.B. Saunders, 2002; 404-5.
32. Craven DE, Duncan RA, Stram JR, et al. Response of lymphoepithelial parotid cysts to antiretroviral treatment in HIV-infected adults. Ann Intern Med 1998; 128: 455-9.